RAMAT GAN, Israel

以色列，拉马特甘

,

，

June 25, 2026

2026年6月25日

/PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:

/美通社/ -- Pulsenmore Ltd.（纳斯达克：

PLSM

PLSM

) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it has entered into a securities purchase agreement with a healthcare-focused institutional investor, for the purchase and sale of 1,562,500 ordinary shares (or pre-funded warrants in lieu thereof) and ordinary warrants to purchase up to 1,562,500 ordinary shares in a private placement at a combined purchase price of $4.80 per ordinary share and accompanying warrant  (or $4.7999 per pre-funded warrant and accompanying ordinary warrant), representing a premium to the Nasdaq Minimum Price under Nasdaq rules.

（特拉维夫证券交易所股票代码：PLSM）作为家用超声技术的先驱，今日宣布已与一家专注于医疗保健领域的机构投资者签订证券购买协议，以私募方式买卖1,562,500股普通股（或预付认股权证以替代普通股）以及最多可认购1,562,500股普通股的普通认股权证，每股普通股及附带认股权证的合并购买价格为4.80美元（或每份预付认股权证及附带普通认股权证的价格为4.7999美元），该价格高于纳斯达克规则规定的最低价格。

The gross proceeds from the offering are expected to be approximately $7.5 million, before deducting placement agent commissions and other estimated offering expenses. The ordinary warrants will have an exercise price of $4.80 per share, will be exercisable immediately upon issuance, and will expire five years following the date of issuance.

本次发行的总收益预计在扣除配售代理佣金及其他预估发行费用前约为750万美元。普通认股权证的行权价格为每股4.80美元，自发行之日起即可行权，并于发行日五年后到期。

The pre-funded warrants will have at an exercise price of $0.0001 per share and will be exercisable immediately until exercised in full..

预付融资认股权证的行权价格为每股0.0001美元，可立即行权，直至全部行权完毕。

Elazar Sonnenschein, Chief Executive Officer of Pulsenmore commented, 'This financing supports our next phase of growth and is intended to enable us to further expand our commercial footprint, particularly in the U.S. market, increase market penetration, and execute on strategic initiatives designed to drive long-term growth.

Pulsenmore 首席执行官 Elazar Sonnenschein 表示：“此次融资将支持我们的下一阶段增长，旨在帮助我们进一步扩大商业布局，尤其是在美国市场，提高市场渗透率，并执行旨在推动长期增长的战略举措。”

We remain focused on advancing our mission, strengthening our market position, and delivering sustainable value to all stakeholders.'.

我们继续专注于推进我们的使命，加强市场地位，并为所有利益相关者创造可持续的价值。

The closing of the Offering is expected to occur on or about June 26, 2026, subject to the satisfaction of customary closing conditions. The Company currently intends to use the net proceeds from the Offering for marketing and commercialization activities, working capital and other general corporate purposes..

本次发行的交割预计将于2026年6月26日或前后进行，但须满足惯常的交割条件。公司目前打算将本次发行所得款项净额用于营销和商业化活动、营运资金以及其他一般公司用途。

A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offering.

A.G.P./Alliance Global Partners 担任本次发行的独家配售代理。

The offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended (the 'Securities Act'), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or applicable state securities laws.

上述证券的发售和销售系依据经修订的《1933年证券法》（以下简称“《证券法》”）第4(a)(2)条及其下颁布的D条例，以及适用的州证券法中关于注册要求的豁免规定进行；该等证券未曾且初始亦不会根据《证券法》或适用的州证券法进行注册。

Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investor, the Company has agreed to file a registration statement with the U.S.

因此，除非依据生效的注册声明或适用《证券法》及相应州证券法律中关于注册要求的豁免规定，否则不得在美国境内发售或出售该等证券。根据与投资者签订的证券购买协议的条款，公司已同意向美国提交一份注册声明。

Securities and Exchange Commission (the 'SEC') covering the resale of the ordinary shares and ordinary shares underlying Warrants sold in the Offering..

美国证券交易委员会（“SEC”）关于在本次发行中出售的普通股及认股权证所涉普通股的转售事宜。

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction..

本新闻稿不构成出售要约或购买所发行证券的要约邀请，也不得在任何此类要约、邀请或销售在根据该州或司法管辖区的证券法进行注册或资格认定之前属违法的州或司法管辖区进行这些证券的销售。

About Pulsenmore

关于 Pulsenmore

Pulsenmore Ltd. is dedicated to revolutionizing maternal health through home-use ultrasound technology that connects mothers and healthcare providers remotely. By leveraging advanced imaging and telemedicine, Pulsenmore makes prenatal care patient-centric, expanding access and improving continuity of care.

Pulsenmore Ltd. 致力于通过家用超声技术革新母婴健康，该技术可远程连接孕妇与医疗保健提供者。借助先进的成像技术和远程医疗，Pulsenmore 使产前护理以患者为中心，扩大服务可及性并提升护理的连续性。

For more information, visit .

更多信息，请访问。

www.pulsenmore.com

www.pulsenmore.com

Forward-Looking Statements

前瞻性陈述

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, statements using words such as 'may,' 'seek,' 'will,' 'consider,' 'likely,' 'assume,' 'estimate,' 'expect,' 'anticipate,' 'intend,' 'believe,' 'contemplate,' 'do not believe,' 'aim,' 'goal,' 'due,' 'predict,' 'plan,' 'project,' 'continue,' 'potential,' 'positioned,' 'guidance,' 'objective,' 'outlook,' 'trends,' 'future,' 'could,' 'would,' 'should,' 'target,' 'on track' or their negatives or variations, and similar terminology and words of similar import, generally involve future or forward-looking statements.

本新闻稿包含1933年《证券法》第27A条和1934年《证券交易法》第21E条所定义的“前瞻性陈述”。特别是，使用诸如“可能”、“寻求”、“将”、“考虑”、“可能”、“假设”、“估计”、“预期”、“预计”、“打算”、“相信”、“设想”、“不相信”、“旨在”、“目标”、“由于”、“预测”、“计划”、“规划”、“继续”、“潜在”、“定位”、“指引”、“目的”、“展望”、“趋势”、“未来”、“可以”、“将会”、“应当”、“靶向”、“按计划进行”等词语或其否定形式或变体，以及类似术语和具有类似含义的措辞的陈述，通常涉及未来或前瞻性陈述。

Such forward-looking statements include, but are not limited to, the anticipated gross proceeds from the Offering, the intended use of proceeds therefrom, the satisfaction of customary closing conditions, and the expected timing and completion of the Offering. Forward-looking statements reflect Pulsenmore's current views, plans, or expectations with respect to future events or financial performance.

此类前瞻性陈述包括但不限于：对此次发行预计募集资金总额的预期、对该等募集资金拟用途的说明、对惯例交割条件获满足的预期，以及对此次发行预期时间安排及完成情况的展望。前瞻性陈述反映了Pulsenmore目前对未来事件或财务表现的观点、计划或预期。

They are inherently subject to significant business, economic, competitive, and other risks, uncertainties, and contingencies. Forward-looking statements are based on Pulsenmore's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including, but not limited to, the following: the Company's lack of operating history; the Company's current and future capital requirements and the Company's belief that its existing cash will be sufficient to fund its operations for more than one year from the date that the financial statements are issued; the Company's ability to manufacture, market and sell its products and to generate re.

它们本质上受到重大业务、经济、竞争及其他风险、不确定性和偶然事件的影响。前瞻性陈述基于Pulsenmore当前的预期，并受限于难以预测的固有风险、不确定性和假设，包括但不限于以下各项：公司缺乏经营历史；公司当前及未来的资本需求，以及公司认为其现有现金足以支持自财务报表发布之日起超过一年的运营；公司制造、营销和销售其产品并产生收入的能力。

Investor Contact:

投资者联系：

Miri Segal-Scharia

米里·塞加尔-沙里亚

MS-IR LLC

MS-IR 有限责任公司

[email protected]

[email protected]

Logo -

标志 -

https://mma.prnewswire.com/media/2942134/Pulsenmore_Logo.jpg

https://mma.prnewswire.com/media/2942134/Pulsenmore_Logo.jpg

SOURCE Pulsenmore Ltd.

来源 Pulsenmore 有限公司

21

二十一

%

%

more press release views with

更多新闻稿浏览量，借助

Request a Demo

申请演示